Iovance Biotherapeutics (IOVA) Earnings Date & Reports

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune systemâ€™s ability to recognize and destroy diverse cancer cells using therapies personalized for each patient... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

IOVA is expected to report earnings to fall 7.58% to -24 cents per share on May 13

Iovance Biotherapeutics IOVA Stock Earnings Reports

Q1'25

Est.

$-0.24

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.02

Q2'24

Beat

by $0.01

Q1'24

Est.

$-0.42

The last earnings report on February 27 showed earnings per share of -25 cents, beating the estimate of -27 cents. With 7.11M shares outstanding, the current market capitalization sits at 1.05B.

View a ticker or compare two or three

Compare

IOVA